Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.78 GBX | -0.88% | +1.13% | -11.10% |
May. 08 | UBS raises Centrica to 'buy' from 'neutral | AN |
Apr. 12 | JPMorgan raises Taylor Wimpey, Persimmon | AN |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- The company appears to be poorly valued given its net asset value.
- This company will be of major interest to investors in search of a high dividend stock.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Analyst opinion has improved significantly over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- With a 2024 P/E ratio at 42.78 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialized REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-11.10% | 1.62B | C+ | ||
+12.32% | 60.56B | A- | ||
-1.87% | 19.76B | A- | ||
+0.45% | 14B | A | ||
-0.10% | 7.57B | B | ||
-7.89% | 6.01B | B- | ||
+12.06% | 3.56B | C- | ||
+0.46% | 3.32B | C+ | ||
-4.32% | 3.15B | B+ | ||
+2.04% | 3.01B | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- AGR Stock
- Ratings Assura Plc